Lawsuit Alleges CVS Health Diverted $41M in Prescription Drug Revenue
What happened
The University of Kentucky filed a federal lawsuit against CVS Health Corporation, alleging fraud, RICO conspiracy, and breach of contract. The suit claims CVS allegedly diverted $41 million in prescription drug revenue belonging to the university over five years, despite having a 340B pharmacy agreement with CVS. The university stated that CVS charged full price instead of the discounted rates required by the agreement.
From kykernel.com
Why it matters
The allegations come amid broader legal challenges facing CVS Health, Walgreens, and Rite Aid related to the opioid crisis. The lawsuit highlights potential systemic issues regarding discounted drug pricing and regulatory compliance within the healthcare sector.
CVS Health, Walgreens, and Rite Aid are facing opioid crisis lawsuits, including a recent ruling stating CVS was not entitled to insurer coverage from AIG and Chubb.
From kykernel.com
Who's involved
- UK HealthCareThe health care system at the University of Kentucky, which filed the lawsuit.
Keep exploring
Part of
CVS Health, Walgreens, and Rite Aid are facing opioid crisis lawsuits, with a recent ruling stating CVS was not entitled to insurer coverage from AIG and Chubb.Also in this story
- CVS Pharmacy Inc. settled a case regarding alleged unlawful opioid dispensing practices.
- CVS Health is capitalizing on the market retreats of Rite Aid and Walgreens, while leveraging its Aetna segment for growth.